Registered Kenya · PPB

PROSTIN E2

DIPROSTONE

4950 3MG

What it does

Diprostone is a medication used to help with certain childbirth processes.

Commonly used for: inducing labor, preparing the cervix for delivery

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
4950
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
DIPROSTONE
Dosage form
3MG
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Pfizer
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Friedrichstraße 110, 10117 Berlin, Germany

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:47:38 · updated 2026-03-23 04:32:49

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Diprostone is a medication used to help with certain childbirth processes.

What it treats

  • inducing labor
  • preparing the cervix for delivery

How it works

Diprostone helps to soften and open the cervix, making it easier for a woman to give birth.

Who it's for

This medication is for pregnant women who need assistance with labor.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: diprostone

Diprostone is a synthetic prostaglandin analog used primarily in obstetrics for its ability to induce labor and facilitate cervical ripening. It is administered locally to the cervix and acts by mimicking the natural prostaglandins that promote uterine contractions and soften the cervix, making it suitable for childbirth.

Indications

  • Cervical ripening in pregnant women at term
  • Induction of labor

Dosage

Children: Not applicable or referenced.

Adults: Refer to the BNF for specific dosing guidelines.

Mechanism of action

Diprostone exerts its effects by binding to prostaglandin receptors, leading to an increase in intracellular calcium levels and enhanced myometrial contractility. This action promotes cervical dilation and effacement, facilitating the onset of labor.

Pharmacodynamics

As a prostaglandin E2 analog, diprostone influences smooth muscle relaxation and contraction. Its effects are mediated through the activation of specific G-protein coupled receptors, leading to changes in calcium ion concentration within uterine and cervical tissues. This not only aids in cervical ripening but also promotes effective uterine contractions during labor.

Pharmacokinetics

Diprostone is rapidly absorbed at the site of administration. Its bioavailability, distribution, metabolism, and excretion profiles are consistent with those of other prostaglandins. The onset of action occurs within hours, and its effects may last for several hours depending on the dose and individual patient response. Metabolism primarily occurs in the liver, with renal excretion of metabolites.

Contra-indications

  • Hypersensitivity to diprostone or any of its components
  • Active vaginal bleeding
  • History of uterine surgery including cesarean delivery
  • Multiple gestation (e.g., twins, triplets)

Adverse effects

  • Uterine hyperstimulation
  • Vaginal bleeding
  • Fetal heart rate abnormalities
  • Infection
  • Nausea and vomiting
  • Diarrhea
  • Headache

Interactions

  • Oxytocin may enhance the uterine stimulation effects of diprostone
  • Other uterotonics may increase the risk of uterine hyperstimulation

Precautions

  • Use with caution in patients with a history of uterine hypertonicity
  • Monitor fetal heart rate and uterine activity closely during administration
  • Consider potential risks in patients with cardiovascular disease or other significant comorbidities

Pregnancy

Diprostone is used for cervical ripening and induction of labor in pregnant women.

Breast-feeding

It is not known whether diprostone is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat, and protect from light.

Formulations

  • Vaginal insert (e.g., dinoprostone controlled-release insert)
  • Gel for intracervical use

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.